Status:
UNKNOWN
A Clinical Trial of a Radiation Sensitizer in Radiochemotherapy for Thoracic Esophageal Squamous Carcinoma
Lead Sponsor:
Shandong Luye Pharmaceutical Co., Ltd.
Conditions:
Esophageal Carcinoma
Eligibility:
All Genders
18-70 years
Phase:
PHASE4
Brief Summary
This multicentered clinical trial is going to find out the radio-sensitization action of sodium glycididazole in radiochemotherapy for esophageal cancer.
Detailed Description
Esophageal cancer is one of the most frequent causes of cancer death in the world. The most common type of esophageal cancer is squamous cell carcinoma (SCC) in China. Although concurrent radiochemoth...
Eligibility Criteria
Inclusion
- written informed consent
- photographically and histologically proven thoracic esophageal squamous carcinoma
- stages 2a-3, and stage 4 with only supraclavicular lymph nodes metastasis defined by AJCC(2002)
- radiochemotherapy indication
- measurable tumor
- adequate hematologic, hepatic and renal function
- Karnofsky performance status ≥70
- age more than 18years and less than 70 years
Exclusion
- pregnancy and lactation
- significant neurologic disease
- severe liver and renal malfunction,and Significant medical illness
- previous chemotherapy, radiotherapy or immunotherapy
- esophagus hemorrhage and esophagus perforation features
Key Trial Info
Start Date :
April 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2009
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00642239
Start Date
April 1 2008
End Date
December 1 2009
Last Update
May 14 2008
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100036
2
Cancer Center of Sun Yat-sen University
Guangzhou, Guangdong, China, 510060
3
Zhongshan Hospital of Fudan University
Shanghai, Shanghai Municipality, China, 200032
4
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, China, 100021